Using GLP-1 Agonists with Biologics in Autoimmune Conditions

Can they be combined? The short answer: YES. GLP-1 agonists like semaglutide and tirzepatide can be used alongside biologics for conditions such as rheumatoid arthritis or psoriatic arthritis.

How Biologics Work

Biologics help suppress an overactive immune system, reducing inflammation and preventing the body from attacking itself. For many, this is enough to control symptoms, but not always.

GLP-1 Agonists and Metabolic Health

GLP-1 agonists regulate metabolic health, improving blood sugar levels and reducing risks of fatty liver, heart attacks, and strokes. They also benefit those with autoimmune conditions, where chronic inflammation increases metabolic risks, and vice versa.

A Dual Benefit

Combining GLP-1 agonists with biologics offers both metabolic and inflammatory health benefits. For patients with autoimmune conditions and rising blood sugar or a family history of heart disease, this combination could improve overall health and reduce long-term risks.

Conclusion

GLP-1 agonists are a valuable addition to biologics in managing both inflammation and metabolic health in chronic autoimmune conditions. Consult your physician to see if this option suits your needs.